TY - CHAP M1 - Book, Section TI - PERCUTANEOUS CORONARY INTERVENTIONS IN ACUTE MYOCARDIAL INFARCTION AND ACUTE CORONARY SYNDROMES A1 - O’Neill, William A1 - Grines, Cindy A1 - Dangas, George A2 - Fuster, Valentin A2 - Harrington, Robert A. A2 - Narula, Jagat A2 - Eapen, Zubin J. PY - 2017 T2 - Hurst's The Heart, 14e AB - At its inception,1 coronary angioplasty was envisioned as a procedure for patients with stable, single-vessel coronary artery disease (CAD). Original angioplasty balloon catheters were too large, bulky, and difficult to navigate through vessels other than the proximal portions of major epicardial vessels. Coronary lesions were required to be concentric and noncalcified. Even in these simple lesions, the initial success rate was 64%.2 Over the past 40 years, improvements in catheter design, development of atraumatic steerable guidewires, development of flexible, highly deliverable stents, and development of highly effective antithrombotic and antiplatelet therapy have made percutaneous coronary intervention (PCI) a dominant revascularization strategy. Furthermore, use of PCI has revolutionized the care of patients with acute myocardial infarction (AMI) and acute coronary syndrome (ACS). SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/28 UR - accesscardiology.mhmedical.com/content.aspx?aid=1161730727 ER -